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Abstract
The aim of this study was to review the latest findings about the neural plasticity on the
adenosinergic neural  network after  the exposition to hypoxia.  Identification of  the
neuromorphology that supports the physiological adaptations underlying the response
of  organisms  to  environmental  factors  including  injurious  exposures  (specifically
hypoxia) has been one of the major research challenges in biomedicine. To know these
responses would connect the metabolic needs and the vegetative neuronal networks in
an integrated way. Hypoxia refers to a state in which oxygen supply is insufficient and
several neural cardiorespiratory structures are responsible for correcting and prevent‐
ing its effects. Although hypoxia is often a pathological condition, variations in arterial
oxygen concentrations can be part of the normal physiological responses, for example,
during hypoventilation training or  strenuous physical  exercise.  Also,  hypoxia  is  a
serious consequence of preterm birth in the neonate. Neural plasticity is a persistent
change in the morphology and/or function based on prior experiences, and it is crucial
for understanding its effects. Plasticity is well evident when the triggering experience
occurs early in life; but in the case of respiratory control plasticity, could also be present
in adult life. The regulation of adenosinergic neural network maturation, especially in
central cardiorespiratory areas, could provide new perspectives in respiratory new‐born
distress symptoms.
Keywords: hypoxia, purinergic network, adenosine, central respiratory control, neu‐
ronal plasticity
1. Introduction
One of the main functions of the cardiorespiratory system is to guarantee that all tissues are
adequately oxygenated at all time, maintaining the normal mitochondrial oxidative process and
ATP production. The most common electron acceptor is molecular oxygen (O2), and when O2 is
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present, the mitochondria will undergo aerobic respiration. To maintain O2 levels, in healthy
animals, ventilation is tightly controlled by a system that must maintain the precise constancy
of alveolar and arterial blood gases and acid‐base status, as well as minimizing the work and
metabolic  cost  of  breathing.  Deviations from these normal values lead to hypoxic tissue
environments [1–6].
In mammals, a lack of O2 (hypoxia) induces acute reflexes including increasing ventilation and
sympathetic tone in order to almost immediately improve the uptake and distribution of O2
to all tissues of the organism. When the conditions of hypoxia were prolonged, during hours
or days, as a defence mechanism it would induce the expression of different genes that,
consequently, would modify the ATP metabolism. Indeed, all the homeostatic control of the
animal would be affected and other changes would be induced such as increased ventilation,
erythropoiesis and angiogenesis, all of that would results in improved O2 tissue levels. In order
to produce the complete response to hypoxia, a group of specialized cells are key to mediate
these fast reflex responses. These cells are crucial because they are capable of sensing small
variations of O2, and this information is crucial to maintain O2 homeostasis. Among the organs
that respond acutely to hypoxia, the carotid body (CB) is currently attracting renewed medical
interest, as its over‐activation seems to be involved in the autonomous dysfunction that
accompanies numerous highly prevalent disorders such as sleep apnoea, diabetes, hyperten‐
sion and chronic heart failure [1–6].
The aim of this study was to review the latest findings about the neural plasticity of the
adenosinergic neural network implicated in the central regulation of breathing after the
exposition to hypoxia. Four types of hypoxia are currently known: first, the hypoxemic type,
in which the blood O2 levels fall down and they could not saturate the molecules of haemo‐
globin. Secondly, in the anaemic type, low concentrations of functional haemoglobin avoid the
erythrocytes that could make an effective transportation of O2.Thirdly, the stagnant type, in
which hemodynamic is altered and the velocity and volume of the blood flow is diminished,
as that occurs in shock or syncope. Finally, the histotoxic hypoxia was referred to a reduction
due to a deficiency in the utilization of O2 by the cells. To compensate for hypoxia, cardiovas‐
cular and respiratory functions are implemented increasing the cardiac rhythm, causing
hypertension, modifying the ventilatory rhythm and increasing the activity of the accessory
breathing muscles of neck and upper chest. As the hypoxia continues to worsen, these
compensatory mechanisms would begin to fail [1–6].
All of these systemic responses are controlled by specific brain areas that integrate the
information about the hypoxic conditions and conduct the changes during the hypoxic insult
to initiate an adaptive process. As in other systems, the neural plasticity is a central cue for the
cardiovascular and respiratory responses to the hypoxia functional adaptation. Neural
plasticity implies a persistent change in the morphology and/or function based on prior
experiences and it is crucial for understanding the changes in the central control of cardior‐
espiratory functions. Plasticity is well evident when the triggering experience occurs early in
life; but in the case of respiratory central control, plasticity could also be present in adult life
[3, 5, 7–11]. Since ATP production is compromised during exposure to hypoxia, it is interesting
to try to discuss the possible role of the purinergic signalling, in general, and the neuronal
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adenosinergic network, among other neural structures, responsible of the defence response
against hypoxia. This interplay could confer emergent properties to the central respiratory
control system. Understanding these mechanisms and their interactions may enable us to
optimize hypoxia‐induced plasticity as a way to improve treatments for patients that suffer
from different ventilatory impairments or other related pathologies [1–6]. On the other hand,
the hypoxic hypometabolism differs in adults or young animals. Indeed, it would have a more
evident effect in mammals when the levels of O2 consumption are higher (i.e. in small or young
animals when they are exposed to cold). It is clear that a good strategical adaptation to low
O2 levels (hypoxia) requires coordinated down‐regulation of metabolic demand, as well as
tissue supply, in order to prevent a mismatch in ATP utilization and production that might
end in a bioenergetic collapse. In this way, substantial experimental evidence suggests that
common integrative structures are probably involved in the metabolic and ventilatory
responses to hypoxia [12–15]. The synthesis of adenosine is related to the cellular ratio AMP/
ATP (Figure 1) and, obviously, to the energy metabolism of cells. In addition, in the central
nervous system (CNS), an increase in neuronal activity needs a higher expense of energy and,
for this reason, the extracellular levels of adenosine would be modified. The adenosinergic
system acts, in CNS, to bind adenosine to one of the different adenosine receptors (A‐Rs).
Usually, the increased high levels of extracellular adenosine would induce a decrease in
neuronal activity. Because the cells reduce its activity, its need for energy falls down too. This
nucleoside usually acts via receptor‐dependent mechanisms, and could also use receptor‐
independent mechanisms. Anyway, its complex and wide range of actions imply that
adenosine could have a significant role in the defence against cell damage in areas of increased
energy requirements, in tissues as well as in recovering the normal/physiological state from a
pathologic one [6, 12–22].
Furthermore, the above‐mentioned hypometabolism is mediated by an activation of the
chemoreceptors by depletion in the arterial O2 partial pressure (PaO2) among other factors. The
sensing of the PaO2 is the principal afferent pathway to modify the alveolar ventilation, which
assure the O2 supply. Thus, arterial chemoreceptors (aortic bodies and CBs) serve an important
role in the control of alveolar ventilation, but they also exert a powerful influence on cardio‐
vascular function. Aortic bodies sense likewise the levels of arterial carbon dioxide partial
pressure (PaCO2) to regulate the depth and rhythm of breathing, but not changes in the blood
H+ concentration ([H+]). To detect this last factor it is necessary to understand the role of the
CB that detects all the previously described arterial variables, and, as its major quality, they do
not desensitize. Finally, central chemoreceptors located on the ventrolateral surface of medulla
oblongata detect changes in cerebrospinal fluid [H+] (Figure 1) [5–7, 9–11].
It is obvious then that the hypoxic response is a complex effect that must be studied at different
levels, including the central areas where the respiratory rhythm and pattern is generated, as
well as newly described functions of the CB, the integrative nature of central chemoreceptors
and the interaction between peripheral and central chemoreception. Furthermore, it must be
also taken into account the metabolic signalling influence of purinergic control, in general, and,
in particular, the adenosinergic influence [1, 13, 17, 18, 23, 24].
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Figure 1. Schematic diagram of the hypoxic response generated at the ventrolateral medulla after the integration of
peripheral and central chemoreceptors, including the role of metabolic signalling within the central neuronal network.
Abbreviations: 12, hypoglossal nucleus; py, pyramidal tract; Sp5, spinal trigeminal nucleus.
2. Brain, hypoxia and pathophysiology
Normal breathing must be continuously adjusted to maintain homeostasis of arterial blood
gases by means of feedback, feedforward and adaptive control strategies that depend of the
brainstem respiratory network. How this process is centrally controlled is still under discus‐
sion, despite the advances (especially thanks to the development of in vitro preparations) that
have been recently made [2, 3, 6, 7]. The precise mechanisms (cellular, synaptic and molecular)
that underlie the generation and modulation of respiratory rhythm/pattern still remain largely
unknown. This lack of fundamental knowledge in the field of neural control of respiration,
and its relationship with other neurovegetative controls, is likely due to the complexity of the
mammalian brain where synaptic connectivity between central cardiorespiratory neurons,
motoneurons and their peripheral counterparts, to the present day, cannot be reliably mapped
[2, 3, 7, 8].
Adaptive responses have evolved in different animal species to guarantee a sufficient supply
of O2 to tissues and to facilitate the survival of cells under transient or sustained conditions of
limited O2 availability. Although hypoxia is often related to a pathological condition, it is of
great importance to recognize that variations in PaO2 can be part of normal situations that
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require strenuous physiological responses, for example, during hypoventilation training or
intense physical exercise [4, 5, 16, 21, 25–28]. It has to be also taken into account the condition
of hypercapnia that results from an excess of PaCO2, which results in acidification of blood and
tissues. The respiratory central medullary rhythm/pattern generator must respond to these
chemosensory cues to maintain O2 and carbon dioxide (CO2) homeostasis in the blood and
tissues. To do so, sensorial cells located in the periphery and CNS monitors the PaO2 and PaCO2
and initiates respiratory and autonomic reflex adjustments during hypoxic and hypercapnic.
Activation of either the hypoxic or hypercapnic chemoreflex elicits both hyperventilation and
sympathetic activation [4, 5, 16, 25–28]. However, the hypoxic insult is a fundamental drive to
increase respiratory rate.
Traditionally, physiological research has been focused on the effect of a chronic sustained
hypoxia (CH), but relatively few works were directed to the effect of periods of intermittent
hypoxia that is maintained chronically. However, the different protocols resemble several
pathological states that occur when patients suffer discontinuous expositions to hypoxia by
malfunction of the ventilatory system. Nevertheless, these chronic intermittent hypoxia (CIH)
laboratory protocols vary greatly between researches in lifespan of hypoxic exposure periods,
numbers of hypoxic episodes per day and the total number of days of exposure. In any case,
and in spite of the lack of a uniform definition, most of the recent data suggest that animals
exposed to CIH would present multiple long‐term pathophysiological consequences that are
similar to those observed in clinic and, for that, it would be a good animal model to study
different respiratory pathologies [4, 5, 16, 21, 25–28].
2.1. The role of carotid body as chemoreceptor
O2 sensing is necessary for the activation of cardiorespiratory reflexes that permit the survival
of individuals under hypoxic environments, like high altitude or pathological conditions (with
reduced capacity for gas exchange between the lung alveoli and the blood). Changes are
detected by the arterial chemoreceptors, in particular CB, to facilitate rapid adaptations to
hypoxia including hyperventilation and sympathetic activation. The CB is located at the
carotid bifurcation although its precise location varies between mammalian species. The CB is
composed of functional units named glomeruli, which are clusters of cells separated by a
profuse network of small capillaries and connective tissue. Each glomerulus (in close contact
with blood vessels and nerve fibres) contains neuron‐like glomus (or type I) cells, which can
be easily identified because they are strongly dopaminergic. Glomus cells are surrounded by
processes of sustentacular (type II) cells that are positive for antibodies against glial fibrillary
acidic protein and other glial markers. It has been shown that type II cells, or a subpopulation
of them, are quiescent stem cells that are activated under hypoxia to proliferate and differen‐
tiate into glomus and other cell types [5, 9–11]. Glomus neuron‐like cells contain O2‐sensitive
K+ channels, which are inhibited by hypoxia acting through several mechanisms, including
release of gaseous transmitters (NO, CO, H2S), AMP‐activated protein kinases and/or reactive
oxygen species. Finally, it has been demonstrated that CBs are polymodal receptors that would
respond not only to modifications in PaO2, PaCO2 and H+, but also to stimuli as K+, several
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neurotransmitters (i.e. norepinephrine), changes in temperature and osmolarity, as well as
variations in the levels of glucose or insulin. Furthermore, reductions in CB blood flow (in
addition to a decrease in PaO2) also provide powerful CB stimulation and remodelling over
time [5, 9–11].
The feedback from the CB is sent to the cardiorespiratory centres in the medulla oblongata via
the afferent branches of the glossopharyngeal nerve. The afferent neurons to CB have their
somas in the petrosal ganglion. This ganglion is anatomically distinct in several species of
mammals like cat and rabbit, but in others (i.e. rat) it is part of a structure that includes the
jugular and nodose ganglia. Their afferent fibres project to the commissural or medial subnu‐
clei of the nucleus tractus solitarius (NTS) (Figure 1) that convey sensory information regarding
cardiorespiratory homeostasis in the form of graded action potential frequencies in fibres of
the carotid sinus branch of the ninth cranial (glossopharyngeal) nerve. The efferent innervation
arises primarily from the sympathetic fibres originating from the superior cervical ganglion
constituting the ganglio‐glomerular nerve. Efferent innervation may best be considered as a
modulating influence affecting the CB chemosensitivity largely, but not solely, via a modula‐
tion of CB blood flow [5, 7–11, 29, 30].
2.2. Central integrative chemoreception process
The brainstem is the central structure that operates the integrative process of the different
chemoreceptors and baroreceptors inputs and which also generates the respiratory rhythm/
pattern. From these structures it should be outlined that the NTS is composed of a series of
clusters of neuronal cell bodies forming a vertical column of grey matter embedded in the
dorsal medulla oblongata. The NTS projects to, among other regions, the reticular formation,
parasympathetic preganglionic neurons, hypothalamus and thalamus, conforming circuits
that contribute to autonomic regulation (Figure 1). Anatomical and physiological experiments
have shown that the dorsomedial part of the NTS is the primary termination site of glosso‐
pharyngeal and vagal baroreceptors, integrating the baroreceptor afferents, while the midline
area, caudal to the calamus scriptorius, has been identified as a primary central termination site
for CB afferents. The NTS neurons are stimulated by hypoxia or hypercapnia, and most
profoundly by a combination of both. Under normal or pathological conditions, CB informa‐
tion reaches the respiratory pattern generator neuronal network via NTS glutamatergic
neurons, which also target the rostral ventrolateral medulla oblongata (RVLM) presympathetic
neurons, thereby raising sympathetic nerve activity (Figure 1). For that, NTS second‐order
neurons could induce chemoreceptor reflex responses that include hyperpnoea, bradycardia
and a sympathetically mediated vasoconstriction for a long‐term acclimatization to hypoxia
[5, 7, 9–11, 29, 30].
Other group of neurons to be highlighted is the RVLM, containing several functionally distinct
types of neurons, which control and orchestrate cardiovascular and respiratory responses to
hypoxia and hypercapnia (Figure 1) [3, 7, 8, 29, 30]. At this level, chemoreceptors regulate
presympathetic neurons and cardiovagal preganglionic neurons indirectly via inputs from the
neurons related to the respiratory pattern generator. Secondary effects of chemoreceptors on
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the autonomic outflows result from changes in lung stretch afferent and baroreceptor activity
[3, 7, 8, 29, 30].
On the other hand, central respiratory chemosensitivity is caused by direct effects of cerebro‐
spinal [H+] on neurons and indirect effects of CO2 via astrocytes. Central respiratory chemo‐
receptors are not definitively identified but several brainstem areas have been demonstrated
to have a role as chemoreceptor. First, the retrotrapezoid nucleus (RTN), located at the rostral
end of RVLM, is a particularly strong candidate (Figure 1). Indeed, the absence of RTN likely
causes severe central apnoeas in congenital central hypoventilation syndrome. The RTN
chemoreceptor neurons provide a CO2/H+‐dependent drive to breathe and serve as an
integrator centre of convergence of chemosensory information from other central and periph‐
eral sites, including the CBs. Finally, the RTN chemosensitive neurons also appear to serve as
important sites of integration of several stimuli, as these neurons are significantly modulated
by inputs from vagal‐mediated pulmonary stretch receptors and from the hypothalamus [29,
30].
Another cluster of RVLM cells (constituted by a population of C1 catecholaminergic neurons)
controls sympathetic vasomotor tone in resting and in hypoxic and hypercapnic conditions,
including the peripheral chemoreflex [29, 30]. The increased sympathetic outflow elicited by
peripheral chemoreceptors is mediated primarily by activation of the presympathetic neurons
of the RVLM, the majority of which are C1 neurons. In fact, the cardiorespiratory effects of
peripheral chemoreceptors are mediated in part by the direct glutamatergic inputs from the
NTS to C1 neurons (Figure 1) [2, 3, 7, 8, 29, 30].
Recently, the description of the structures related to the respiratory rhythmogenesis has
improved with the advent of the in vitro neonatal rodent brainstem preparation [31]. This
recording technique has allowed for precise identification of specific medullary sites for
separate but coupled rhythm generation or “oscillators”. These neurons reside in the pre‐
Bötzinger complex and in the parafacial respiratory group (pFRG) located in the RVLM [29,
30]. The most exciting result so far was the finding that some inspiratory neurons in RVLM act
as inspiratory pacemakers; they continue to produce rhythmic bursts of potentials even when
the synaptic connections are blocked [2]. Although the inspiratory pacemaker neurons do not
constitute a well‐defined group within the medulla, this group of neurons named pre‐
Bötzinger complex certainly play an important role in the generation and/or modulation of the
breathing rhythm [2]. Of the several models proposed for generating respiratory rhythm, the
most promising appears to be a hybrid model, which combines emergent properties of
networks of synaptic connections and intrinsic membrane properties of individual neurons
together with independent pacemaker‐type neurons [1– 3, 7, 8, 23, 29, 30].
Furthermore, several facts support that the pFRG/RTN complex is likely to be the major site
of central CO2 chemo‐responsiveness. First, pFRG/RTN is characterized by glutamatergic
interneurons that strongly express Phox2b (that codes for the homeodomain transcription
factor expressed exclusively in the nervous system, in most neurons that control the viscera,
like cardiovascular, digestive and respiratory systems). Besides, the Phox2b neurons are part
of an uninterrupted chain of neurons in a circuit that includes the CBs and their afferents as
well as the NTS projections to the RTN. The functional consequences of this linkage are that
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stimulation of the peripheral chemoreceptors enhances the slope of the central CO2 ventilatory
response,and conversely, inhibition of the CBs reduces the slope of the central CO2 response
[1–3, 7, 8, 23, 29, 30].
Another interesting central chemosensitive area is the caudal parapyramidal (Ppy), located
near the ventral surface of the medulla, at the level of the pyramidal decussation and may
function as well as the pFRG/RTN complex (Figure 1). Furthermore, medullary neurons
activated in response to hypercapnia were only found in the Ppy area. Nevertheless, neurons
in both regions, RTN and PPy, could belong to the same cell population based on their
histochemical and physiological properties and their location, near the medullary surface that
facilitates the sensing of the arterial composition [1, 23].
In any case, the brainstem cardiorespiratory control areas are connected with other areas such
as periaqueductal gray (PAG), hypothalamus, amygdala, cortex and cerebellum (Figure 1).
These areas also exert influences over the respiratory rhythm/pattern generator. In this way, it
has been found, from data obtained by clinical evidences in patients submitted to deep brain
stimulation (by means of stimulating electrodes that recorded field potentials during neuro‐
surgical procedures), that the PAG and the subthalamic nucleus have a key role in activating
the central command of cardiorespiratory responses to stress. The PAG is an integrative
structure that maintains a wide network of connectivity with different neural systems, such as
prefrontal cortex, hypothalamus and nociceptive pathways. Moreover, the PAG efferent
projections also addressed to the medullary cardiorespiratory control areas. Finally, anatom‐
ical evidences support the connectivity to amygdala and cortex from RVLM and neurons of
the respiratory pattern generator that supports, among others effects, the vegetative correlate
of emotions or learning (Figure 1) [3, 7, 8, 30, 31].
All of the above described structures are part of an extended neuronal network that participates
in the regulation and integration of cardiovascular and respiratory functions. From all of the
neurotransmitters shared by this complex neuronal network, the purinergic network is one of
the choices to regulate the physiologic responses to hypoxia. Recent evidence suggests that
ATP‐mediated purinergic signalling at the level of the RVLM coordinates cardiorespiratory
responses triggered by hypoxia and hypercapnia by activating RTN and C1 neurons, respec‐
tively. For all of that, the role of ATP‐mediated signalling in the RVLM must be critical for
cardiovascular and respiratory activities (Figure 1) [3, 7, 8, 29, 30].
2.3. Pathophysiological responses to hypoxia
Since the condition in which the whole body (or a region) was exposed to variations in arterial
O2 concentrations can be part of the normal physiology, a mild and non‐damaging intermittent
hypoxia (IH) is used intentionally, for example, during altitude training to develop an athletic
performance adaptation at both the systemic and cellular level [4, 5, 16, 21, 26–28]. However,
hypoxia is a deprivation of adequate O2 supply at the tissue level and, often, a pathological
condition with very serious consequences of preterm birth in the neonate, for example. The
main cause for this pathology is that the lungs of the human foetus are among the last organs
to develop during pregnancy. The perinatal hypoxic‐ischemic cerebral injuries found in the
clinic are a main problem of paediatrics because of its severe consequences for the posterior
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development of the infants, such as the appearances of cerebral paralysis. Accumulating
evidence points to an evolving process of brain injury after intrapartum hypoxia‐ischemia,
initiated in utero and extending into a recovery period. This process in the neonate originates
numerous functional deficits, such as impaired resting ventilation and ventilatory response to
hypoxia [17, 28, 31, 32].
On the other hand, abnormalities or mutations of the medullary neuronal breathing rhythm/
pattern networks may also have a great impact on the progress of human diseases in children
or adults. Failures in the breathing pattern with severe consequences are well‐documented.
These problems, often cause CO2 retention in awake, and in particular, in sleeping subjects,
that could be associated to neurodegenerative diseases such as Parkinson's disease, amyotro‐
phic lateral sclerosis or post‐polio syndrome. It is also been proved that these breathing
alterations are often associated to medullary and multiple system atrophy of patients. These
syndromes have been linked to deficits in neurons related with the respiratory control in the
pre‐Bötzinger complex, pontine raphe and adjacent areas. Obviously, an understanding of how
the response to hypoxia is organized and when or why the system become maladapted and
could induce cell damage is extremely important for knowing how to fight against the diseases
in the future [4, 5, 16, 21, 26–28].
It is well known that disruption of the drive to breathe is thought to contribute to the mortality
of certain pathologies, including stroke or epilepsy, and it is the cause of sudden infant death
syndrome (SIDS) [1–6]. In the case of SIDS, it has generally been accepted that, in the absence
of trauma, children death occurs to either respiratory or circulatory failure. The events appear
to be a sequential process, first hypoxia occurs, and then there must be a failure to recover from
hypoxia. The failure to recover could occur when the infant does not arouse from sleep
and/or self‐resuscitation mechanisms fail. For that, it has been proposed that there should be
three necessary components for development of SIDS: congenital or acquired vulnerability, a
critical “time‐window” during maturational development and an acute stressor. The arousal
response is essential for avoiding the hypoxic conditions due to certain microenvironments
that could cause the loss of consciousness or the risk of dying. A failure of the neural system
that would induce the arousal response from sleep, in the hypoxic condition, could be related
to the progress or, in certain cases, the fatal result in diagnosed SIDS. However, these kinds of
malfunctions do not explain all the process that should appear in SIDS. In fact, it seems clear
that an initial respiratory failure and hypoxemia ignites the sequence of responses that,
dramatically, may cause the death. Respiratory chemoreceptor studies on infants at risk for
SIDS have suggested that a decreased sensitivity to CO2 could play a causal role in these
deaths [1–6, 33].
Concerning CB function, there is a significant increase in sensitivity of the peripheral chemo‐
receptors during the first few weeks of life and it has been frequently shown that CB dener‐
vation in animal models is followed by hypoventilation and sudden death later on. Therefore,
these denervated animals for the most part are markedly symptomatic prior to death. The
principal problem in translating these results to humans is that SIDS infants do not appear to
have any symptoms before death. This fact implies that it could be a problem related to the
central integration of CB information in SIDS, but its role is still under discussion. However,
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CB must be taken into account in the pathogeny of SIDS, because a partial decrease in the
sensitivity to hypercapnia or hypoxemia would be a causal role in this syndrome [2, 33].
Several studies indicate that changes in the strength and/or pattern of respiratory‐sympathetic
coupling may have pathological implications in the control of arterial pressure levels. Such
dysfunctions can be observed in the experimental condition of CIH, and also is commonly
observed in patients suffering from obstructive sleep apnoea (OSA). OSA consists of a
repetitive obstruction of the upper airways during sleep. Each obstruction causes an episode
of hypoxia leading to a picture of CIH causing a fall in the PaO2 and arterial haemoglobin
saturation. OSA is characterized by repetitive collapse or near collapse of the upper airway
during sleep, and these repetitive events impose substantial adverse effects on multiple organ
systems. As a result of these mechanical changes in the airway, hypoxemia and hypercapnia
develop, which further stimulate respiratory effort. Without airway opening the increased
drive is ineffective at increasing ventilation. Hypoxic episodes stimulate the CB, triggering an
increased motor muscles towards the inspiratory output and an arousal reaction, which
together solve the obstruction [1–6]. Following even very brief periods of IH interspersed with
normoxia, hyperventilation and increased sympathetic activity are sustained over an hour or
more (i.e. the so‐called long‐term facilitation). Central adaptive responses occur following CIH
in the persistent elevation of tonic hyperactivity of neurons at the level of the hypothalamus
and other structures [4, 16, 21, 26–28]. As OSA progresses, it frequently generates a syndrome
with associated pathologies at different systems: cardiovascular (hypertension and augmented
acute vascular accidents), hepato‐metabolic (insulin resistance, glucose intolerance, fatty liver
disease) and neuropsychiatric (anxiety, depression and cognitive‐executive deficits). Clinical
and experimental studies indicate that CIH is an important event in the occurrence of OSA‐
associated pathologies because it causes CB sensitization [1–6]. The process probably includes
increasing CB chemoreceptor input to the brainstem leading to an exaggerated sympathetic
tone, which generates hypertension and subsequent cardiovascular and metabolic pathologies.
In OSA patients, the repetitive respiratory events lead to IH and CO2 retention, both of which
can augment sympathetic nerve activity via stimulation of central and peripheral chemore‐
ceptors. Conditions of hypoxia, both chronic and intermittent lack of O2, seem to induce CNS
plasticity of respiratory and sympathetic functions neuronal networks and metabolic changes
that could also lead to pathological states [4, 5, 27, 28].
3. Purinergic neuronal networks and hypoxia
ATP is released in an activity‐dependent manner from different cell types in the brain, fulfilling
different roles as a neurotransmitter, neuromodulator, in astrocyte‐to‐neuron communication,
propagating astrocytic responses and modulating microglia responses. So, purinergic signal‐
ling has been found to contribute at all levels of the nervous system, including enteric,
autonomic and central [34–38]. The term purinergic receptor was classically introduced to
name specific classes of membrane receptors that mediate the release of ATP (P2 receptors) or
adenosine (P1 receptors). The group of adenosine P1 receptors (A1‐R, A2a‐R, A2b‐R, A3‐R) are
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expressed on presynaptic and postsynaptic neurons, on astrocytes, microglia and mature and
precursor oligodendrocytes. The mechanisms of ATP signalling are equally diverse, acting by
means of P2 receptors, including ionotropic (P2X‐R) and metabotropic (P2Y‐R) subtypes, as
well as varying methods of transmission, including vesicular, volume‐regulated anion channel
and gap junction hemichannel release of ATP from neuronal and non‐neuronal cells [34–38].
ATP is involved in central respiratory control and may mediate changes in the activity of
medullary respiratory neurons during hypercapnia. The P2 receptor family comprises seven
ionotropic P2X‐R subunits (P2X1‐7), forming both homomeric or heteromeric receptors and
eight metabotropic P2Y‐R subtypes (P2Y1, 2, 4, 6, 11, 12, 13, 14). The brain displays a robust
mRNA expression, an intense binding, and immunoreactivity for both P2X‐R and P2Y‐R in
neuronal and non‐neuronal elements, although the role of central P2‐R remains ill defined.
The ATP‐mediated signalling in respiratory control and central chemoreception is associated
to the profile of the P2X2‐R subunit. This subunit is expressed, by physiologically identified
respiratory neurons, in areas of the ventral medulla, the pontine locus coeruleus, the NTS, and
the raphe nuclei. There are several evidences that sustain the hypothesis that purinergic
signalling could play a central role in the mechanisms underlying the chemosensitivity of
RVLM (Figure 1). It has been demonstrated the responses evoked by ATP in neurons express‐
ing P2X‐Rs to changes in extracellular [H+]. In that way, this evidence supports the putative
mechanism of chemosensitivity of RVLM cells, and it would be necessary the tonic release of
ATP. This may be the case, when P2‐R blockade reduces the baseline firing of RVLM respiratory
neurones. The modulation of P2X2‐R function, evoked by acidification of the extracellular
environment during hypercapnia, contributes to the changes in activity of the RVLM respira‐
tory neurones that express these receptors [34–38].
Furthermore, it has been shown that several medullary areas may have chemosensitive
responses mediated by ATP. In this way, experiments made in brain slices using cell‐attached
recordings of membrane potentials have shown that CO2/H+‐receptive NTS neurons are
activated by focal ATP applications. However, it has been evidenced that purinergic P2‐R
blockade did not affect their CO2/H+ responsiveness [38]. On the other hand, CO2/H+‐sensitive
raphe neurons were unaffected by ATP or P2‐R blockade [34, 38]. When the experiments where
realized in vivo, ATP injection into the NTS increased cardiorespiratory activity; however,
injections of a P2‐R antagonist into this area did not change the baseline breathing or the CO2/
H+ responsiveness [34, 38]. Indeed, a significant proportion of respiratory neurones located in
the vicinity of the Bötzinger and pre‐Bötzinger areas express the P2X2‐R subunit and respond
with an increase in discharge during ATP application. This fact could mean that purinergic
signalling plays an additional role in the generation and shaping of central respiratory output,
as well as premotoneurons that are responsible for transmitting this rhythm to the spinal
motoneurons controlling the diaphragm and intercostal muscles [34–38].
Finally, as above stated, RVLM contributes to peripheral chemoreceptor modulation of
breathing and blood pressure, by chemosensitive RTN neurons and presympathetic C1
neurons, respectively, and these neurons are activated by purinergic agonists. In contrast,
the blockade of P2‐Rs in the RVLM blunted cardiorespiratory responses to peripheral che‐
moreceptor activation in anesthetized rats [34–38]. RTN neuronal activity was found to be
Hypoxia Modulates the Adenosinergic Neural Network
http://dx.doi.org/10.5772/65242
257
independent of temperature and stimulus strength and was wholly retained when synap‐
tic activity was blocked using high‐Mg++, low‐Ca++ solution. In the RTN, mechanisms of
chemoreception involved direct H+‐mediated activation of chemosensitive neurons and in‐
direct modulation by purinergic signalling. This modulation implies a CO2/H+‐evoked ATP
release by RTN astrocytes, contributing to respiratory drive. ATP injection into the RTN
increased breathing and blood pressure by a P2‐R dependent mechanism, at the cellular
and systems level [38]. However, because the results using antagonists of P2‐R and focal
injections did not elucidate the cells that were responsible, it is necessary more experimen‐
tal evidence to determine the putative chemoreceptors and, if it is the case, the above ob‐
served effects could be indirect ones. Nevertheless, purinergic signalling also modulates
the activity of CO2/H+‐sensitive neurons at least in two other brainstem regions thought to
contribute to central chemoreception (i.e. the caudal NTS and medullary raphe). In any
case, these evidences suggest that purinergic signalling is a unique feature of RTN chemo‐
reception and point out to a unique CO2/H+ sensing mechanism in the RTN [34–38].
4. Adenosine receptors, brain development and pathophysiological
hypoxic response
The role of adenosine, as an extracellular signalling molecule, was defined after the observa‐
tions of the ability of purines to control the functioning of the heart. Adenosine modulates the
activity of the nervous system at cellular level both presynaptically by inhibiting or facilitat‐
ing transmitter release, and postsynaptically by hyperpolarising or depolarising neurons, as
well as exerting non‐synaptic effects (i.e. on glial cells). It is usually assumed that adenosiner‐
gic signalling provides a neuroprotective role. However, several researches have shown that,
under determined circumstances, changes in the levels of adenosine could have the opposite
effects, contributing to neuronal damage and cell death [6, 12–15, 19–22]. These two ways of
actions could be determined by the union of adenosine to different subtypes of A‐Rs. Further‐
more, changes in the levels of expression of the different subtypes, interactions between these
receptors, differential actions on neuronal and glial cells and several “time‐windows” (that
are critical during development) could also provide different actions at different events, as
well as adenosinergic agonist and antagonist compounds administration. Moreover, adeno‐
sine do not work isolated, and, in spite of this, it is still unclear if the role of A‐R subtypes (A1‐
R and A2‐R) in the control of neuroprotection is mostly due to the control of glutamatergic
transmission. Another possible role of adenosine is that its protection is mediated by one of
the homeostatic roles of its receptors, such as control of metabolism, neuroglial communica‐
tion, inflammatory response, neurogenesis or mechanism of action of growth factors [6, 12–
15, 19–22].
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the CNS
[6, 12–22]. The adenosine role as a neuromodulator is especially important around the time of
birth and is involved in the suppression of foetal and neonatal breathing, particularly during
hypoxia when extracellular levels of this nucleoside rapidly increase. Apnoea of prematurity,
defined as cessation of breathing lasting longer than 15 s and accompanied by bradycardia or
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hypoxia, is common occurring in 85% of infants born less than 34‐week gestation. Preterm
birth constitutes approximately 6–12% of all births in industrialized countries and accounts
for 70% of neonatal mortality and 75% of neonatal morbidity [6, 12–21]. Depending on
gestational age and birth weight, preterm infants present a wide range of abnormal physio‐
logical responses due to their immature organ systems [17, 28, 31, 32]. During development
A1‐Rs are especially important, being the earliest receptors expressed in the embryonic brain
and heart. A1‐R activation potently inhibits the development of axons and can lead to leuko‐
malacia [18, 32].
The most common method of treatment of the apnoeas of prematurity is continuous
positive airway pressure and administration of a methylxanthine. The family of methyl‐
xanthines includes caffeine (1, 3, 7‐trimethylxanthine), one of the most popular human
stimulants, and all of them derivate from xanthine, that is a purine present in human and
other organism's tissues and fluids. This group of alkaloids has therapeutically been used
for their effects stimulating respiratory function by means of its excitatory effects on the
CNS, because of its capacity to suppress respiratory depression, reduce periodic breathing
and enhance diaphragmatic activity. Caffeine also increases ventilatory drive and im‐
proves sensitivity and/or responsiveness to changes in the level of PaO2 [6, 12–22]. The
discovery that methylxanthines acted as antagonists of adenosine receptors represented a
crucial step to establish the idea that adenosine indeed acted as an extracellular signalling
molecule operating on selective receptors. Caffeine, at high doses, can also inhibit phos‐
phodiesterases, block GABAa receptors or cause a release of intracellular Ca++. Further‐
more, caffeine acts on the respiratory cycle by antagonizing the actions of endogenous
A1‐R, A2a‐R or A2b‐R [6, 12–22]. Studies on A1‐R have demonstrated that these receptors
are found at high density in the brainstem and hypothalamus while A2a‐Rs are widely
distributed in the medulla [14, 17, 18]. Animal studies have shown that caffeine treatment
alters A‐R expression and distribution, cause transient motor impairments and could also
be neurotoxic to the newborn. In rats, limited exposure to therapeutic doses of caffeine
during early life (postnatal days 3–6, P3–P6) changes the distribution, density and sensi‐
tivity of A1‐Rs in several regions of the CNS; these changes could persist until adulthood.
Caffeine treatment at P2–P6 mimics the clinical use of caffeine in human neonates. Since
the relative level of maturation of the CNS in newborn rats in the first week of life is
similar to that of a premature newborn human between 20 and 40 weeks postconception,
newborn rats could serve as a suitable animal model to test the potential impact of peri‐
natal caffeine treatment on the adenosinergic system. The oral administration of caffeine
in critical periods of newborn rat and immunohistological experiments showed an in‐
crease of A1‐R labelling in restricted cardiorespiratory related areas. These labelled struc‐
tures were the anterior hypothalamic area, ventromedial hypothalamic nucleus,
parabrachial complex and ventrolateral medulla of the caffeine‐treated group at P6. For
the subtype A2a‐R, it was found a moderate increase of immunolabelling in pontome‐
dullary and other hypothalamic areas also related to vegetative functions. Indeed, in‐
creased A1‐R and A2a‐R gene expression was observed in both the brainstem and
hypothalamus at P5. These results showed an up‐regulation of adenosinergic maturation
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in central cardiorespiratory areas when the animals were caffeine treated in the neonatal
period and could explain the pharmacological effects observed in caffeine treated prema‐
ture infants, and it would also imply that caffeine mediated a modification of the post‐
natal development of the adenosinergic system during a critical period or “time‐window”
[6, 12–22]. To date, human data show that such caffeine treatment has no major side
effects on neurodevelopmental outcome in children in the 38–42 weeks following birth
and up to 2 years after the treatment. However, further research is required to determine
the long‐term pathologic and functional effects of caffeine and the combination of caffeine
and other substances on the developing immature brain [6, 12–22].
Anyway, adenosine, is not only crucial in development, it also mediates multifactorial forms
of ventilatory responses. The reduced hypoxic ventilatory response could be attributed to
depressed adenosinergic peripheral excitatory mechanisms and to enhanced adenosinergic
central depression mechanisms, both of which contribute to the blunted ventilatory response
in different metabolic states (Figure 1). Several important groups of clinical studies, in which
the adenosinergic network role has been demonstrated, are related to OSA, asthma and inter‐
stitial lung disease such as idiopathic pulmonary fibrosis (IPF) [1–6]. Levels of adenosine re‐
ceptors are altered in the lungs of asthmatics and OSA patients and a recent study has shown
that the A2b‐R is increased in remodelled airway epithelial cells of rapidly progressing IPF
patients [6, 12–22]. Furthermore, CIH (as an experimental OSA model) elicits phrenic long‐
term facilitation by an adenosine‐dependent mechanism [2, 6, 12–22]. All of the above are
interesting evidences about the mechanisms that support and induce inflammatory and tis‐
sue remodelling processes in these pathological states; however, it is necessary to do more
research on the pathways that provoke their progressive and chronic evolution. For example,
there are already implemented several models of deregulated or overactive wound healing
pathways to explain how these processes contribute to an excessive remodelling response
such as seen in chronic lung disease [2, 6, 12–22]. Consistent with this, adenosine levels are
elevated in the lungs of patients with chronic lung disease, where it is hypothesized that ade‐
nosine regulates the balance between tissue repair and excessive airway remodelling. Fur‐
thermore, it has been demonstrated that exogenous adenosine treatment can elicit acute
bronchoconstriction in patients with asthma or OSA [1–6]. In contrast, the administration of
adenosine to healthy subject did not affect them, suggesting a fundamental difference with
respect to adenosinergic signalling in the treated patients. The differential response could be
mediated by the activation of A‐Rs that would modify the activity of different cell types that
play a central role in chronic lung disease. These groups of possible targets include mast cells,
eosinophils, macrophages, airway epithelial cells, pulmonary fibroblasts and airway smooth
muscle cells. Indeed, recent studies directly demonstrate that adenosine is involved in the
regulation of pulmonary fibrosis. Lastly, there are correlations between the degree of inflam‐
mation and damage and adenosine accumulations in adenosine deaminase‐deficient individ‐
uals. Furthermore, purinergic metabolism and signalling components are altered in a manner
that promotes adenosine production in tissue samples from patients with OSA and IPF. These
modifications were related to the very important changes found in the expression of the pro‐
moter molecules of inflammatory process that could be induced by A2b‐R signalling. Finally,
it was interesting to point out that it has been demonstrated that activation of A2b‐Rs can
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influence the production of inflammatory and fibrotic mediators from macrophages isolated
from these patients [6, 12–22].
All of the above findings suggest that adenosine‐based therapeutics may be beneficial in the
treatment of chronic lung diseases such as OSA and IPF. On the other hand, it is known that
inflammation‐induced release of prostaglandin E2 changes breathing patterns and the re‐
sponse to CO2 levels. This bioactive eicosanoid regulates many biologically important proc‐
esses as a potent activator of several signalling pathways, through four distinct G‐protein‐
coupled receptors. All of this alters neural network activity in the pre‐Bötzinger rhythm‐
generating complex and in the chemosensitive brainstem respiratory regions, thereby
increasing sigh frequency and the depth of inspiration with implications for inspiration and
sighs throughout life, and the ability to autoresuscitate when breathing fails [2, 6, 7, 12–15, 19–
22, 29, 30].
5. Conclusion
Identification of the neurophysiological mechanisms underlying the response of organisms to
environmental factors, in particular, to injurious exposures like hypoxia, represents one of the
most important research problems in biomedicine. Neural plasticity, as a persistent change in
the morphology and/or function based on prior experiences, is crucial for understanding the
effects of O2 supply changes over neuronal networks. Plasticity is well evident when the
triggering experience occurs early in life; but in the case of respiratory control plasticity, could
also be present in adult life. The regulation of adenosinergic neural network maturation,
especially in central cardiorespiratory areas, could provide new perspectives in respiratory
newborn distress symptoms. Adenosine acts as an extracellular signalling molecule operating
on selective receptors. Regulation of adenosinergic maturation in central cardiorespiratory
areas in caffeine‐treated neonatal mammals could explain the pharmacological effects of
caffeine observed in premature infants. Anyhow, the neuroplasticity observed in the cardior‐
espiratory network is fundamental to maintain life in many adverse conditions.
The central and peripheral chemical drive to breathe is associated with several widespread
autonomic disorders. Deficits in central chemical drive are associated with central sleep
apnoea, a debilitating disease with few therapies besides constant positive airway pressure.
In addition, disruption of the drive to breathe is thought to contribute to mortality of certain
pathologies, including SIDS, stroke and epilepsy. Finally, in OSA, certain forms of hypertension
and heart failure, it has been observed sensitization of peripheral chemoreceptor drive,
particularly the sympathetic component and this over‐activity is thought to contribute to the
pathology.
Purinergic signalling has been proposed to be an excellent system to target for therapies of
numerous pathologies, mainly due to novel pharmacological agents being developed. As more
detailed understanding of the purinergic mechanisms involved in the chemical drive to breathe
are uncovered, these would allow to possible pharmacological treatments of the aforemen‐
tioned pathologies with the newly developed purinergic agents.
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